Conned Altrus

Quote






























I am getting my Ass kicked out here! Any hype on Altrus is over. Covidien and J & J rule. Now I even have my Doc's that were willing to try the Altrus now want to try Aesculap's new device first. DM and SM have put 80% of their NEW sales force on a performance plan due to lack of sales. What a Joke! I would love to see DM and SM try and sell this product. Looking to get out of this mess quick!! It's sad because I have gone through extensive training and have only been here 1 1/2.
 






Is there not a single application/specialty in which you could win? Trying giving the box for free in exchange for disposables. Isn't the Altrus device better than EnSeal and Ligasure?
 






Anonymous said:
Is there not a single application/specialty in which you could win? Trying giving the box for free in exchange for disposables. Isn't the Altrus device better than EnSeal and Ligasure?
Click to expand...

Better how? At this point there is very little difference among the vessel sealers on the market (except Gyrus - that thing sucks) and the big boys already have their pieces of capital in the OR or are on a GPO contract. All you can hope for is to compete on price and that is going to obliterate the projected (and unrealistic) IRR that was hoped for. Aragon/Aesculap has more inertia at this point and the articulation is a nice feature, so it's understandable that you'd have to wait in line behind them.
 
























Total BS, I have been with Conmed for over 2 years and have posted on here at least once a month. SM can't figure out who is writing on here. Just write your posts from your personal computers.
 


















ConMed took the only real proprietary technology (argon beam) and squandered it. You notice how the 2012 model ABC looks like the 1997 model? Instead of putting millions of dollars into a me-too product (Altrus), the could have developed argon beam coagulation and increased the indication, therefore standing out from the crowd. Now they have investors getting testy about their ROI with Altrus.

How much longer will JC be grabbing his ankles? An absolutely horrible, mismanaged company.
 






























Corasanti reiterated in the investor conference call that he sees between $5-10M in Altrus sales in 2012. The only reason he gives is the market is so huge. Now that is sophisticated analysis! This company will never sell more than $5M in a single year....and will lose accounts as soon as they are converted to competing technologies with very large sales teams.
 






Top Bottom
Back
Quote